Novartis will be able to introduce Sandoz’s Zarxio (filgrastim) after Sept. 2, the U.S. Court of Appeal for the Federal Circuit ruled Wednesday.
Access to healthcare drove 82.9% more blood pressure screenings and 26.9% more diabetes screenings.
Patients surfing the content on Elsevier's Health Library can search by a specific condition or diagnosis or move through an easy-to-skim, A-to-Z list of healthcare topics.
Amneal Pharmaceuticals has introduced four new products since June.
As many as 12% of pet owners have bought health insurance for their animals. And among millennials, that number jumps to 19%.
Galderma Laboratories announced Thursday that the Food and Drug Administration had approved it Epiduo Forte Gel, an antibiotic-free daily treatment for acne vulgaris.
Increasing access to birth control through the pharmacy may pose a challenge - will pharmacists who counsel patients on family planning be reimbursed for their efforts?
The Food and Drug Administration is exploring extending PDUFA through 2022.
The new guidelines have been expected to increase the number of statin-eligible adults by almost 13 million.